Balasa Dinverno & Foltz’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $6.67M | Sell |
40,860
-219
| -0.5% | -$37.1K | 0.42% | 28 |
|
|
2022
Q2 | $7.29M | Buy |
41,079
+1,086
| +3% | +$193K | 0.46% | 26 |
|
|
2022
Q1 | $7.09M | Sell |
39,993
-190
| -0.5% | -$32.3K | 0.48% | 24 |
|
|
2021
Q4 | $6.87M | Sell |
40,183
-7,416
| -16% | -$1.21M | 0.44% | 26 |
|
|
2021
Q3 | $7.69M | Buy |
47,599
+671
| +1% | +$114K | 0.54% | 22 |
|
|
2021
Q2 | $7.73M | Buy |
46,928
+3,997
| +9% | +$662K | 0.56% | 21 |
|
|
2021
Q1 | $7.06M | Buy |
42,931
+5,283
| +14% | +$855K | 0.57% | 20 |
|
|
2020
Q4 | $5.92M | Buy |
37,648
+6,812
| +22% | +$1.01M | 0.49% | 23 |
|
|
2020
Q3 | $4.59M | Buy |
30,836
+1,503
| +5% | +$222K | 0.44% | 26 |
|
|
2020
Q2 | $4.13M | Buy |
29,333
+570
| +2% | +$83.1K | 0.46% | 23 |
|
|
2020
Q1 | $3.77M | Buy |
28,763
+3,653
| +15% | +$518K | 0.47% | 25 |
|
|
2019
Q4 | $3.66M | Buy |
25,110
+1,091
| +5% | +$148K | 0.39% | 26 |
|
|
2019
Q3 | $3.11M | Sell |
24,019
-917
| -4% | -$121K | 0.36% | 24 |
|
|
2019
Q2 | $3.47M | Buy |
24,936
+510
| +2% | +$70.6K | 0.4% | 19 |
|
|
2019
Q1 | $3.42M | Sell |
24,426
-264
| -1% | -$35.4K | 0.41% | 19 |
|
|
2018
Q4 | $3.19M | Buy |
24,690
+205
| +0.8% | +$28.6K | 0.4% | 21 |
|
|
2018
Q3 | $3.38M | Buy |
24,485
+188
| +0.8% | +$25K | 0.38% | 20 |
|
|
2018
Q2 | $2.95M | Sell |
24,297
-2,416
| -9% | -$301K | 0.43% | 18 |
|
|
2018
Q1 | $3.42M | Sell |
26,713
-2,022
| -7% | -$273K | 0.52% | 14 |
|
|
2017
Q4 | $4.01M | Sell |
28,735
-105
| -0.4% | -$14.6K | 0.6% | 13 |
|
|
2017
Q3 | $3.75M | Buy |
28,840
+2,139
| +8% | +$284K | 0.59% | 11 |
|
|
2017
Q2 | $3.53M | Buy |
26,701
+2,427
| +10% | +$310K | 0.57% | 11 |
|
|
2017
Q1 | $3.02M | Buy |
24,274
+1,462
| +6% | +$175K | 0.51% | 15 |
|
|
2016
Q4 | $2.63M | Buy |
22,812
+1,463
| +7% | +$169K | 0.45% | 19 |
|
|
2016
Q3 | $2.52M | Buy |
21,349
+843
| +4% | +$102K | 0.46% | 13 |
|
|
2016
Q2 | $2.49M | Buy |
20,506
+1,264
| +7% | +$144K | 0.44% | 15 |
|
|
2016
Q1 | $2.08M | Buy |
19,242
+1,163
| +6% | +$120K | 0.37% | 17 |
|
|
2015
Q4 | $1.86M | Sell |
18,079
-1
| -0% | -$101 | 0.31% | 21 |
|
|
2015
Q3 | $1.69M | Sell |
18,080
-1,099
| -6% | -$106K | 0.3% | 22 |
|
|
2015
Q2 | $1.87M | Sell |
19,179
-1,333
| -6% | -$133K | 0.3% | 19 |
|
|
2015
Q1 | $2.06M | Sell |
20,512
-871
| -4% | -$88.6K | 0.29% | 23 |
|
|
2014
Q4 | $2.24M | Buy |
21,383
+849
| +4% | +$89.5K | 0.32% | 22 |
|
|
2014
Q3 | $2.19M | Buy |
20,534
+1,144
| +6% | +$119K | 0.33% | 22 |
|
|
2014
Q2 | $2.03M | Sell |
19,390
-154
| -0.8% | -$15.6K | 0.23% | 19 |
|
|
2014
Q1 | $1.92M | Sell |
19,544
-171
| -0.9% | -$15.9K | 0.23% | 20 |
|
|
2013
Q4 | $1.81M | Buy |
19,715
+862
| +5% | +$79.4K | 0.25% | 16 |
|
|
2013
Q3 | $1.63M | Buy |
18,853
+1,980
| +12% | +$178K | 0.27% | 14 |
|
|
2013
Q2 | $1.45M | Buy |
+16,873
| New | +$1.43M | 0.26% | 16 |
|
Other funds holding JNJ
Balasa Dinverno & Foltz's JNJ Position: Q3 2022 in Review
Balasa Dinverno & Foltz reduced its Johnson & Johnson (JNJ) stake by 0.53% in Q3 2022, selling an estimated $37.1K and leaving 40,860 shares worth $6.67M. The position accounts for 0.42% of the portfolio, ranked #28.
Balasa Dinverno & Foltz first reported a position in JNJ in Q2 2013 and has held it in 38 quarters since. The position peaked at $7.73M in Q2 2021. 3,622 funds tracked by Wall St. Rank hold JNJ as of Q3 2022.
- Balasa Dinverno & Foltz held 40,860 shares of Johnson & Johnson worth $6.67M as of Q3 2022.
- Balasa Dinverno & Foltz sold 219 Johnson & Johnson shares in Q3 2022, an estimated $37.1K.
- Johnson & Johnson made up 0.42% of Balasa Dinverno & Foltz's portfolio in Q3 2022, its #28 holding.
- Balasa Dinverno & Foltz first reported a position in Johnson & Johnson in Q2 2013 and has held it in 38 quarters since.
- Balasa Dinverno & Foltz's Johnson & Johnson position peaked at $7.73M in Q2 2021.
- 3,622 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2022.
Based on Balasa Dinverno & Foltz's 13F filing for Q3 2022, filed 25 Oct 2022.